QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NYSE:BY

Byline Bancorp (BY) Stock Forecast, Price & News

$19.46
-0.35 (-1.77%)
(As of 06/8/2023 ET)
Compare
Today's Range
$19.24
$19.74
50-Day Range
$16.87
$21.62
52-Week Range
$16.40
$26.00
Volume
108,125 shs
Average Volume
112,004 shs
Market Capitalization
$733.82 million
P/E Ratio
7.98
Dividend Yield
1.85%
Price Target
$26.33

Byline Bancorp MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
35.3% Upside
$26.33 Price Target
Short Interest
Healthy
4.12% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.00mentions of Byline Bancorp in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$1.99 M Bought Last Quarter
Proj. Earnings Growth
-5.95%
From $2.52 to $2.37 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.73 out of 5 stars

Finance Sector

227th out of 861 stocks

State Commercial Banks Industry

68th out of 178 stocks


BY stock logo

About Byline Bancorp (NYSE:BY) Stock

Byline Bancorp, Inc. is a holding company, which engages in business through its subsidiary, Byline Bank, a full services commercial bank. It offers a broad range of banking products and service to small and medium sized businesses, commercial real estate and financial sponsors, and to consumers in the branch areas. The company was founded on December 29, 1978 and is headquartered in Chicago, IL.

Receive BY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Byline Bancorp and its competitors with MarketBeat's FREE daily newsletter.

BY Stock News Headlines

KBRA Affirms Ratings for Byline Bancorp, Inc.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
KBW Reaffirms Their Hold Rating on Byline Bancorp (BY)
Q1 2023 Byline Bancorp Inc Earnings Call
Piper Sandler Keeps Their Buy Rating on Byline Bancorp (BY)
See More Headlines

BY Price History

BY Company Calendar

Last Earnings
4/27/2023
Ex-Dividend for 5/23 Dividend
5/08/2023
Dividend Payable
5/23/2023
Today
6/08/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
State commercial banks
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
929
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$26.33
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$25.00
Forecasted Upside/Downside
+36.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$87.95 million
Pretax Margin
30.10%

Debt

Sales & Book Value

Annual Sales
$358.87 million
Cash Flow
$2.67 per share
Book Value
$20.44 per share

Miscellaneous

Free Float
24,496,000
Market Cap
$727.80 million
Optionable
Not Optionable
Beta
1.18

Key Executives

  • Roberto R. Herencia
    Executive Chairman & Chief Executive Officer
  • Alberto J. Paracchini
    President & Director
  • Nicolas Mando
    Chief Operations & Technology Officer, SVP
  • Thomas J. BellThomas J. Bell
    Chief Financial Officer, Treasurer & Executive VP
  • Brogan M. Ptacin
    Executive VP & Head-Commercial Banking













BY Stock - Frequently Asked Questions

Should I buy or sell Byline Bancorp stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Byline Bancorp in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" BY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BY, but not buy additional shares or sell existing shares.
View BY analyst ratings
or view top-rated stocks.

What is Byline Bancorp's stock price forecast for 2023?

1 equities research analysts have issued 1-year target prices for Byline Bancorp's stock. Their BY share price forecasts range from $25.00 to $28.00. On average, they expect the company's share price to reach $26.33 in the next twelve months. This suggests a possible upside of 36.4% from the stock's current price.
View analysts price targets for BY
or view top-rated stocks among Wall Street analysts.

How have BY shares performed in 2023?

Byline Bancorp's stock was trading at $22.97 at the beginning of 2023. Since then, BY shares have decreased by 16.0% and is now trading at $19.30.
View the best growth stocks for 2023 here
.

Are investors shorting Byline Bancorp?

Byline Bancorp saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 943,900 shares, a decline of 12.6% from the April 30th total of 1,080,000 shares. Based on an average daily volume of 131,100 shares, the short-interest ratio is presently 7.2 days. Currently, 4.1% of the company's shares are short sold.
View Byline Bancorp's Short Interest
.

When is Byline Bancorp's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our BY earnings forecast
.

How were Byline Bancorp's earnings last quarter?

Byline Bancorp, Inc. (NYSE:BY) issued its quarterly earnings data on Thursday, April, 27th. The company reported $0.65 earnings per share for the quarter, topping analysts' consensus estimates of $0.64 by $0.01. The firm had revenue of $90.86 million for the quarter, compared to analyst estimates of $88.43 million. Byline Bancorp had a net margin of 23.22% and a trailing twelve-month return on equity of 12.03%.

How often does Byline Bancorp pay dividends? What is the dividend yield for Byline Bancorp?

Byline Bancorp announced a quarterly dividend on Thursday, April 27th. Investors of record on Tuesday, May 9th will be paid a dividend of $0.09 per share on Tuesday, May 23rd. This represents a $0.36 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date is Monday, May 8th.
Read our dividend analysis for BY
.

What ETFs hold Byline Bancorp's stock?
Is Byline Bancorp a good dividend stock?

Byline Bancorp (NYSE:BY) pays an annual dividend of $0.36 per share and currently has a dividend yield of 1.87%. The dividend payout ratio is 14.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BY will have a dividend payout ratio of 15.19% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BY.

What is Alberto Paracchini's approval rating as Byline Bancorp's CEO?

20 employees have rated Byline Bancorp Chief Executive Officer Alberto Paracchini on Glassdoor.com. Alberto Paracchini has an approval rating of 35% among the company's employees. This puts Alberto Paracchini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Byline Bancorp own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Byline Bancorp investors own include McDonald's (MCD), Altria Group (MO), AT&T (T), Ares Capital (ARCC), Bank of America (BAC), Franklin Resources (BEN), Emerson Electric (EMR), Invesco (IVZ), Shopify (SHOP) and CarGurus (CARG).

When did Byline Bancorp IPO?

(BY) raised $114 million in an initial public offering (IPO) on Friday, June 30th 2017. The company issued 5,700,000 shares at $19.00-$21.00 per share. BofA Merrill Lynch and Keefe, Bruyette & Woods (A Stifel Company) acted as the underwriters for the IPO and Piper Jaffray, Sandler O’Neill + Partners and Stephens were co-managers.

What is Byline Bancorp's stock symbol?

Byline Bancorp trades on the New York Stock Exchange (NYSE) under the ticker symbol "BY."

Who are Byline Bancorp's major shareholders?

Byline Bancorp's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.67%), Thrivent Financial for Lutherans (5.28%), Dimensional Fund Advisors LP (3.77%), Aristotle Capital Boston LLC (3.10%), State Street Corp (1.88%) and FMR LLC (1.68%). Insiders that own company stock include Ana Casanueva, Brogan Ptacin, Hart Angela E Major, Investors I LP Mbg, John Barkidjija, Lindsay Y Corby, Mary Jo S Herseth, Michelle Lynn Johnson, Owen Beacom, Phillip R Cabrera, Robert R Yohanan, Roberto R Herencia, Steven P Kent, Thomas J Bell III, Valle Perochena Antonio Del and William G Kistner.
View institutional ownership trends
.

How do I buy shares of Byline Bancorp?

Shares of BY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Byline Bancorp's stock price today?

One share of BY stock can currently be purchased for approximately $19.30.

How much money does Byline Bancorp make?

Byline Bancorp (NYSE:BY) has a market capitalization of $727.80 million and generates $358.87 million in revenue each year. The company earns $87.95 million in net income (profit) each year or $2.44 on an earnings per share basis.

How many employees does Byline Bancorp have?

The company employs 929 workers across the globe.

How can I contact Byline Bancorp?

Byline Bancorp's mailing address is 180 NORTH LASALLE STREET SUITE 300, CHICAGO IL, 60601. The official website for the company is www.bylinebancorp.com. The company can be reached via phone at (773) 244-7000 or via email at byir@bylinebank.com.

This page (NYSE:BY) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -